Pharmacist Administration of Long-Acting Injectable Antipsychotics to Community-Dwelling Patients: A Scoping Review.
health services accessibility
injections
long-acting antipsychotic
pharmacist
review
scope of practice
Journal
Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532
Informations de publication
Date de publication:
27 Feb 2023
27 Feb 2023
Historique:
received:
01
02
2023
revised:
14
02
2023
accepted:
21
02
2023
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
Long-acting injectable antipsychotics (LAIAs) have demonstrated positive outcomes for people with serious mental illnesses. They are underused, and access to LAIAs can be challenging. Pharmacies could serve as suitable environments for LAIA injection by pharmacists. To map and characterize the literature regarding the administration of LAIAs by pharmacists, a scoping review was conducted. Electronic-database searches (e.g., PsycINFO, Ovid Medline, Scopus, and Embase) and others including ProQuest Dissertations & Theses Global and Google, were conducted. Citation lists and cited-reference searches were completed. Zotero was used as the reference-management database. Covidence was used for overall review management. Two authors independently screened articles and performed full-text abstractions. From all sources, 292 studies were imported, and 124 duplicates were removed. After screening, 13 studies were included for abstraction. Most articles were published in the US since 2010. Seven studies used database and survey methods, with adherence and patient satisfaction as the main patient-outcomes assessed. Reporting of pharmacists' and patients' perspectives surrounding LAIA administration was minimal and largely anecdotal. Financial analyses for services were also limited. The published literature surrounding pharmacist administration of LAIAs is limited, providing little-to-no guidance for the development and implementation of this service by others.
Identifiants
pubmed: 36961024
pii: pharmacy11020045
doi: 10.3390/pharmacy11020045
pmc: PMC10037648
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Am Pharm Assoc (2003). 2020 Jan - Feb;60(1):178-194
pubmed: 31371179
BMC Med. 2015 Sep 16;13:224
pubmed: 26377409
J Clin Epidemiol. 2016 Jul;75:40-6
pubmed: 27005575
Am J Health Syst Pharm. 2012 Jun 15;69(12):1014-5
pubmed: 22644972
Health Promot J Austr. 2021 Jan;32(1):26-31
pubmed: 31821666
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
BMC Med Res Methodol. 2016 Feb 09;16:15
pubmed: 26857112
J Clin Psychopharmacol. 2020 Jul/Aug;40(4):346-349
pubmed: 32639287
Res Synth Methods. 2014 Dec;5(4):371-85
pubmed: 26052958
Curr Med Res Opin. 2015;31(7):1437-48
pubmed: 25978698
Can J Psychiatry. 2013 May;58(5 Suppl 1):5S-13S
pubmed: 23945067
Public Health. 2014 Apr;128(4):309-16
pubmed: 24713598
J Ment Health. 2016 Dec;25(6):550-559
pubmed: 26607639
J Manag Care Spec Pharm. 2015 Sep;21(9):754-68
pubmed: 26308223
Patient Prefer Adherence. 2013 Nov 13;7:1171-80
pubmed: 24265549
J Clin Pharm Ther. 2017 Aug;42(4):404-413
pubmed: 28485006
Can Pharm J (Ott). 2013 Jan;146(1):39-46
pubmed: 23795168
Ther Adv Psychopharmacol. 2013 Apr;3(2):89-99
pubmed: 24167680
BMC Public Health. 2014 Nov 05;14:1139
pubmed: 25369791
Hosp Pharm. 1976 Oct;11(10):404, 407-8
pubmed: 1028808
Psychiatr Serv. 2009 Aug;60(8):1123-7
pubmed: 19648202
Schizophr Res. 2018 Jul;197:274-280
pubmed: 29274734
J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):22-9
pubmed: 23636152
J Manag Care Spec Pharm. 2022 Oct;28(10):1130-1137
pubmed: 36125056
Pharm Pract (Granada). 2021 Jul-Sep;19(3):2545
pubmed: 34621456
J Clin Epidemiol. 2014 Dec;67(12):1291-4
pubmed: 25034198
BMC Psychiatry. 2013 Dec 20;13:340
pubmed: 24359031
Ther Adv Psychopharmacol. 2019 Jul 03;9:2045125319860977
pubmed: 31321027
J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4S):S29-S34
pubmed: 35177374
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Aust N Z J Psychiatry. 2010 Dec;44(12):1089-96
pubmed: 21070104
Am J Health Syst Pharm. 2012 Nov 15;69(22):2002-5
pubmed: 23135568
J Am Pharm Assoc (2003). 2012;52(6):e252-8
pubmed: 23229987
Res Social Adm Pharm. 2015 May-Jun;11(3):e101-9
pubmed: 23632161
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
J Psychiatr Pract. 2010 Sep;16(5):306-24
pubmed: 20859108
J Clin Psychiatry. 2013 Oct;74(10):957-65
pubmed: 24229745
Eur Neuropsychopharmacol. 2019 Apr;29(4):457-470
pubmed: 30770235
Front Psychiatry. 2021 Dec 15;12:808002
pubmed: 34975600
Cochrane Database Syst Rev. 2019 Dec 23;12:CD013299
pubmed: 31868236
Int J Environ Res Public Health. 2022 Dec 05;19(23):
pubmed: 36498368
BMC Med Res Methodol. 2018 Jan 18;18(1):12
pubmed: 29347910
J Am Pharm Assoc (2003). 2018 Mar - Apr;58(2):156-162.e1
pubmed: 29506660
J Psychopharmacol. 2010 Oct;24(10):1473-82
pubmed: 19477883
BMC Health Serv Res. 2022 Nov 3;22(1):1309
pubmed: 36329439
Lancet Psychiatry. 2021 May;8(5):387-404
pubmed: 33862018
Int J Ment Health Syst. 2014 Nov 21;8(1):46
pubmed: 25473416
Res Social Adm Pharm. 2022 Nov;18(11):3895-3910
pubmed: 35778317
PLoS One. 2022 Apr 29;17(4):e0267808
pubmed: 35486616
J Clin Psychiatry. 2015 Jun;76(6):684-90
pubmed: 25939027
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
BMC Psychiatry. 2013 Oct 16;13:261
pubmed: 24131801
World Psychiatry. 2022 Jun;21(2):248-271
pubmed: 35524619
Res Social Adm Pharm. 2022 May;18(5):2714-2747
pubmed: 34261590
Ther Adv Psychopharmacol. 2014 Oct;4(5):179-85
pubmed: 25360242
BMC Psychiatry. 2018 Jun 14;18(1):192
pubmed: 29898682
CNS Drugs. 2021 May;35(5):469-481
pubmed: 33909272
BMJ Open. 2020 Jul 23;10(7):e039983
pubmed: 32709657
BMC Psychiatry. 2022 Nov 15;22(1):705
pubmed: 36380352
J Am Pharm Assoc (2003). 2018 May - Jun;58(3):290-295
pubmed: 29602746
Curr Rev Clin Exp Pharmacol. 2021;16(1):109-116
pubmed: 32148198
BMJ Open. 2022 Mar 2;12(3):e055597
pubmed: 35236731
Am J Health Syst Pharm. 2017 Jun 1;74(11):766-768
pubmed: 28546295
Healthc Policy. 2011 Feb;6(3):36-46
pubmed: 22294990
BMJ Open. 2016 Sep 20;6(9):e011948
pubmed: 27650763
Adv Ther. 2022 Sep;39(9):3933-3956
pubmed: 35844007
MethodsX. 2021 May 07;8:101375
pubmed: 34430271
Can J Psychiatry. 2022 Mar;67(3):226-234
pubmed: 34792401
Lancet. 2019 Sep 14;394(10202):939-951
pubmed: 31303314
J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4S):S24-S29.e2
pubmed: 30006184
Res Social Adm Pharm. 2020 Apr;16(4):522-528
pubmed: 31327736
J Ment Health. 2018 Apr;27(2):164-173
pubmed: 28675321
Lancet. 2022 Feb 26;399(10327):824-836
pubmed: 35219395
Res Social Adm Pharm. 2015 May-Jun;11(3):364-81
pubmed: 25438728
JAMA Psychiatry. 2017 Jul 1;74(7):686-693
pubmed: 28593216
J Med Econ. 2018 Feb;21(2):127-134
pubmed: 28895758
Res Social Adm Pharm. 2011 Jun;7(2):122-33
pubmed: 21272541